TP53 and non-small cell lung carcinoma: TP53 R175H is a recognized gain-of-function mutation, while TP53 R110C has been observed in isolated cases of colorectal, squamous cell, prostate, and non-small cell lung cancer in the TCGA datasets but has not been specifically identified as a DBD conformational mutant.